T&L Co., Ltd. (KOSDAQ:340570)
South Korea
· Delayed Price · Currency is KRW 49,100
-1,100 (-2.19%)
At close: Dec 5, 2025
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2017 - 2019 |
| Medical and Polymer Material - Product | 167.02B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Medical and Polymer Material - Product Growth | 50.75% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Medical and Polymer Material - Merchandise | 7.87B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Medical and Polymer Material - Merchandise Growth | 68.48% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Wound Treatment - Hydrocolloid | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Wound Treatment - Hydrocolloid Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Wound Treatment - Foam | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Wound Treatment - Foam Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Orthopedic Fixing - Merchandised | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Orthopedic Fixing - Merchandised Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Wound Treatment - Micro Needle | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Wound Treatment - Other | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Wound Treatment - Other Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Orthopedic Fixing - Others | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Orthopedic Fixing - Others Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Orthopedic Fixing - SPLINT | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Orthopedic Fixing - SPLINT Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Orthopedic Fixing - Cast | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Orthopedic Fixing - Cast Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Wound Treatment - Merchandised | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Wound Treatment - Merchandised Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2017 - 2019 |
| Other | 30.70B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | 86.18% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| United States | 103.33B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| United States Growth | 61.61% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| South Korea | 40.86B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| South Korea Growth | 16.64% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | 30.70B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | 86.18% |
Log In |
Log In |
Log In |
Log In | Upgrade
|